Emerging role of non-coding RNAs in the regulation of KRAS

Cancer Cell International

Zeinab Shirvani-Farsani¹  Soudeh Ghafouri-Fard²  Bashdar Mahmud Hussen³  Mohammad Taheri⁴  Reza Jalili Khoshnoud⁵ 

[1] Department of Cellular and Molecular Biology, Faculty of Life Sciences and Technology, Shahid Beheshti University, Tehran, Iran;Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran;Department of Pharmacognosy, College of Pharmacy, Hawler Medical University, Erbil, Iraq;Institute of Human Genetics, Jena University Hospital, Jena, Germany;Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran;Skull Base Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran;

关键词: KRAS;    Oncogene;    lncRNA;    miRNA;    circRNA;   

DOI  :  10.1186/s12935-022-02486-1

来源: Springer

【 摘 要 】

The Kirsten ras oncogene KRAS is a member of the small GTPase superfamily participating in the RAS/MAPK pathway. A single amino acid substitution in KRAS gene has been shown to activate the encoded protein resulting in cell transformation. This oncogene is involved in the malignant transformation in several tissues. Notably, numerous non-coding RNAs have been found to interact with KRAS protein. Such interaction results in a wide array of human disorders, particularly cancers. Orilnc1, KIMAT1, SLCO4A1-AS1, LINC01420, KRAS1P, YWHAE, PART1, MALAT1, PCAT-1, lncRNA-NUTF2P3-001 and TP53TG1 are long non-coding RNAs (lncRNAs) whose interactions with KRAS have been verified in the context of cancer. miR-143, miR-96, miR-134 and miR-126 have also been shown to interact with KRAS in different tissues. Finally, circITGA7, circ_GLG1, circFNTA and circ-MEMO1 are examples of circular RNAs (circRNAs) that interact with KRAS. In this review, we describe the interaction between KRAS and lncRNAs, miRNAs and circRNAs, particularly in the context of cancer.

【 授权许可】

CC BY